These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1704168)

  • 81. [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration].
    Flouvat B; Delhotal B; Kahn JC; Crouzette J; Dubourg O; Roux A; Fodor F; Bourdarias JP
    Therapie; 1984; 39(4):337-44. PubMed ID: 6484877
    [No Abstract]   [Full Text] [Related]  

  • 82. Quinidine on hemodynamics in man. A double blind study of oral treatment with sustained-release tablets for a week.
    Schröder G
    Acta Med Scand; 1966 May; 179(5):543-50. PubMed ID: 5327664
    [No Abstract]   [Full Text] [Related]  

  • 83. Pharmacokinetics of propafenone in the dog after single-dose intravenous administration.
    Puigdemont A; Lligoña LL; Arboix M; de Mora F; Fernandez J
    J Vet Pharmacol Ther; 1987 Dec; 10(4):351-3. PubMed ID: 3437498
    [No Abstract]   [Full Text] [Related]  

  • 84. Studies of plasma quinidine content. III. The value of delayed absorptive coated tablets in oral quinidine therapy.
    SAMPSON JJ; FOREMAN H; SOLOMON BC
    Circulation; 1952 Apr; 5(4):534-8. PubMed ID: 14916470
    [No Abstract]   [Full Text] [Related]  

  • 85. [Blood level studies on the most suitable dosage forms in long-term quinidine therapy].
    Zettner H; Michel D
    Klin Wochenschr; 1971 May; 49(10):575-8. PubMed ID: 5578964
    [No Abstract]   [Full Text] [Related]  

  • 86. [QUINIDINE COMPOUNDS WITH PROLONGED ACTION].
    SIITONEN L
    Duodecim; 1964; 80():686-92. PubMed ID: 14217812
    [No Abstract]   [Full Text] [Related]  

  • 87. Fluorometric measurement of plasma quinidine and its correlation with cardiac effects in man.
    LINENTHAL AJ; ULICK S; PATTERSON LA
    J Clin Invest; 1947 Nov; 26(6):1188. PubMed ID: 20340951
    [No Abstract]   [Full Text] [Related]  

  • 88. Control of quinidine dosage.
    ARCHER HE; WEITZMAN D; KAY HL
    Br Heart J; 1955 Oct; 17(4):534-40. PubMed ID: 13269613
    [No Abstract]   [Full Text] [Related]  

  • 89. A study of quinidine dosage in infants and children.
    NEWTON G; CRAWFORD EJ
    J Pediatr; 1955 Dec; 47(6):700-15. PubMed ID: 13272152
    [No Abstract]   [Full Text] [Related]  

  • 90. Correlation between the effect of quinidine sulfate on the heart and its concentration in the blood plasma.
    WEGRIA R; BOYLE MN
    Am J Med; 1948 Mar; 4(3):373-82. PubMed ID: 18904057
    [No Abstract]   [Full Text] [Related]  

  • 91. Ventricular Tachycardia in Association with Propafenone Overdose.
    Kim HK; Kim SS; Ki YJ; Park KH; Choi DH
    Acta Cardiol Sin; 2021 Jan; 37(1):100-103. PubMed ID: 33488033
    [No Abstract]   [Full Text] [Related]  

  • 92. Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim.
    Trebach J; Mohan S; Hoffman RS
    Acta Cardiol Sin; 2021 May; 37(3):324. PubMed ID: 33976520
    [No Abstract]   [Full Text] [Related]  

  • 93. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
    Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.
    Capucci A; Boriani G; Rubino I; Della Casa S; Sanguinetti M; Magnani B
    Int J Cardiol; 1994 Mar; 43(3):305-13. PubMed ID: 8181888
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.